Dr. Rasha Kelej with Africa First Ladies released “Ray of Hope” - A Storybook and Animation Film to strengthen Cancer ...
Today, the top three high-yield stocks in the Dow are Verizon Communications ( VZ +0.17%) with a lofty 6.8% yield, Chevron ( ...
Chief Executive Officer Belén Garijo used the company’s presentation at the 44th J.P. Morgan Healthcare Conference to outline ...
Merck is in talks to buy cancer drug developer Revolution Medicines in a $28 billion to $32 billion deal, the Financial Times ...
Merck stock surges 30% on strong fundamentals, regulatory catalysts, and attractive valuation. See why I rate the MRK stock a ...
Zacks Investment Research on MSN
Why Merck's 32% rally isn't enough to change the bearish view
Merck’s MRK stock has risen 32.3% in the past three months. The stock has also been trading above its 50-day and 200-day ...
US pharmaceutical group Merck is in talks to buy Revolution Medicines, a cancer drugmaker with a market capitalisation of ...
Merck said on Monday it has raised its outlook for new growth drivers, forecasting $70 billion in revenue from these fresh ...
Merck stock earns a cautious "Buy." Learn more about its valuation, Keytruda risks, pipeline potential, and long-term growth.
Merck CEO Rob Davis expressed high confidence during the company’s J.P. Morgan presentation on Monday, revealing that the ...
The CDC first recommended annual flu shots for all children 6 months and older in 2008, when it expanded the recommendation ...
A key number for Merck in the coming years is $70 billion. This is the mid-2030s revenue opportunity from potential new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results